Total Payments
$56,840
2024 Payments
$45.29
Companies
28
Transactions
439
Medicare Patients
213
Medicare Billing
$21,093
Payment Breakdown by Category
Other$48,275 (84.9%)
Food & Beverage$5,828 (10.3%)
Travel$2,487 (4.4%)
Education$251.01 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,275 | 36 | 84.9% |
| Food and Beverage | $5,828 | 388 | 10.3% |
| Travel and Lodging | $2,487 | 8 | 4.4% |
| Education | $251.01 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $39,269 | 182 | $0 (2020) |
| Neos Therapeutics, LP | $14,262 | 30 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $506.58 | 29 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $486.92 | 23 | $0 (2021) |
| Shire North American Group Inc | $295.79 | 32 | $0 (2019) |
| Lundbeck LLC | $233.52 | 12 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $227.37 | 15 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $206.98 | 14 | $0 (2024) |
| ABBVIE INC. | $172.59 | 20 | $0 (2024) |
| Bausch Health US, LLC | $162.87 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45.29 | 3 | ABBVIE INC. ($22.50) |
| 2023 | $38.86 | 2 | Teva Pharmaceuticals USA, Inc. ($20.32) |
| 2022 | $155.59 | 10 | Teva Pharmaceuticals USA, Inc. ($80.13) |
| 2021 | $1,017 | 79 | AbbVie Inc. ($150.09) |
| 2020 | $1,151 | 67 | Allergan, Inc. ($479.49) |
| 2019 | $10,666 | 90 | Allergan Inc. ($9,898) |
| 2018 | $16,507 | 86 | Allergan Inc. ($10,690) |
| 2017 | $27,259 | 102 | Allergan Inc. ($18,202) |
All Payment Transactions
439 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Central Nervous System | ||||||
| 02/16/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/24/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Central Nervous System | ||||||
| 05/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Central Nervous System | ||||||
| 08/24/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: PSYCHOLOGY | ||||||
| 08/08/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Central Nervous System | ||||||
| 06/06/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Central Nervous System | ||||||
| 05/09/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Central Nervous System | ||||||
| 03/09/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: CNS | ||||||
| 02/07/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Neuropsychiatry | ||||||
| 02/01/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Central Nervous System | ||||||
| 01/07/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/20/2021 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Neurology | ||||||
| 11/16/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $5.48 | General |
| Category: PSYCHOLOGY | ||||||
| 11/08/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2021 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neurology | ||||||
| 11/01/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 10/29/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CNS | ||||||
| 10/27/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $9.76 | General |
| Category: PSYCHOLOGY | ||||||
| 10/15/2021 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/14/2021 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 60 | 124 | $25,180 | $5,845 |
| 2022 | 3 | 70 | 136 | $24,510 | $6,560 |
| 2021 | 1 | 39 | 117 | $16,965 | $4,620 |
| 2020 | 1 | 44 | 136 | $19,720 | $4,068 |
Total Patients
213
Total Services
513
Medicare Billing
$21,093
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 104 | $20,280 | $4,708 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 20 | $4,900 | $1,137 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 109 | $17,805 | $4,102 | 23.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 13 | 13 | $3,775 | $1,624 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 14 | $2,930 | $833.81 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 117 | $16,965 | $4,620 | 27.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 136 | $19,720 | $4,068 | 20.6% |
About Dr. Christopher Okiishi, MD
Dr. Christopher Okiishi, MD is a Psychiatry healthcare provider based in North Liberty, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598750432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Okiishi, MD has received a total of $56,840 in payments from pharmaceutical and medical device companies, with $45.29 received in 2024. These payments were reported across 439 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($48,275).
As a Medicare-enrolled provider, Okiishi has provided services to 213 Medicare beneficiaries, totaling 513 services with total Medicare billing of $21,093. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location North Liberty, IA
- Active Since 09/16/2005
- Last Updated 10/24/2013
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1598750432
Products in Payments
- VRAYLAR (Drug) $39,231
- Adzenys XR-ODT (Drug) $14,262
- REXULTI (Drug) $573.73
- VYVANSE (Drug) $323.21
- LATUDA (Drug) $227.37
- VIIBRYD (Drug) $210.71
- Trintellix (Drug) $210.24
- MYDAYIS (Drug) $168.45
- AUSTEDO (Drug) $167.87
- TRINTELLIX (Drug) $167.77
- ADHANSIA XR (Drug) $161.47
- QELBREE (Drug) $129.55
- APLENZIN (Drug) $125.39
- CAPLYTA (Drug) $113.52
- ABILIFY MAINTENA (Drug) $93.46
- Dyanavel XR (Drug) $81.36
- JORNAY PM (Drug) $62.18
- Dayvigo (Drug) $53.14
- RELEXXII (Drug) $48.78
- INGREZZA (Drug) $47.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.